|
|
2025's Stock Market Performance
|
|
2025's Stock Market Performance
|
2025's Large Cap Stocks Performance
Here are the best and worst performing Large-Cap Stocks of 2025.
The Large-Cap Company is defined with the market capitalization, trading above 5 billion dollars U.S. as of 09/01/26.
2025's Mid Cap Stocks Performance
Here are the best and worst performing companies of 2025 with the market capitalization, trading between 500 million U.S. dollars and 5 billion dollars U.S. respectively, as of 09/01/26.
2025's Small Cap Stocks Performance
The table shows the best and worst performing companies of 2025 with the market capitalization, trading between 50 million U.S. dollars and 500 million dollars U.S. respectively, as of 09/01/26.
2025's Micro Cap Stocks Performance
The list shows the best and worst performing companies of 2025 with the market capitalization, trading under 50 million U.S. dollars, as of 09/01/26.
| The Best Performing Micro-Cap Stocks in 2025 |
2025 |
| Handeni Gold Inc. | Metal Mining Industry |  66,150.00 % | | Applied Uv Inc | Electric & Wiring Equipment Industry | 39,900.00 % | | Ampio Pharmaceuticals inc | Major Pharmaceutical Preparations Industry | 19,900.00 % | | Clever Leaves Holdings Inc | Major Pharmaceutical Preparations Industry | 9,900.00 % | | Kaleido Biosciences Inc | Biotechnology & Pharmaceuticals Industry | 9,900.00 % | | Mj Holdings Inc | Professional Services Industry | 9,900.00 % | | Uscorp | Metal Mining Industry | 9,900.00 % | | Elys Game Technology Corp | Software & Programming Industry | 4,900.00 % | | Cuentas Inc | Wholesale Industry | 2,733.33 % | | Eco Science Solutions Inc | Specialty Retail Industry | 2,140.00 % | | Sonendo Inc | Medical Equipment & Supplies Industry | 1,539.34 % | | Aridis Pharmaceuticals Inc | Major Pharmaceutical Preparations Industry | 1,400.00 % | | Eloxx Pharmaceuticals Inc | Biotechnology & Pharmaceuticals Industry | 1,000.00 % | | Bionik Laboratories Corp | Medical Equipment & Supplies Industry | 900.00 % | | Colombia Energy Resources, Inc. | Coal Mining Industry | 900.00 % | | Panex Resources Inc. | Blank Checks Industry | 900.00 % | | Health Discovery Corporation | Conglomerates Industry | 900.00 % | | Ipic Entertainment Inc. | Restaurants Industry | 900.00 % | | Imageware Systems Inc | Software & Programming Industry | 900.00 % | | Rejuvel Bio-sciences, Inc. | Food Processing Industry | 900.00 % |
Who are the 2025's Stock Market Winners?
IMRX
+197.74%
|
|
|
Immuneering Corporation
Major Pharmaceutical Preparations Industry
IMRX
+197.74%
Immuneering Corp operates on a business model that harnesses the power of big data in the field of biomedicine. Through their proprietary technologies, they analyze vast amounts of biological data to gain insights into disease mechanisms, drug discovery, and patient care. They leverage their expertise to provide pharmaceutical companies and healthcare organizations with actionable information for accelerating the development of new therapeutics and improving clinical outcomes.
|
STTK
+201.65%
|
|
|
Shattuck Labs Inc
Major Pharmaceutical Preparations Industry
STTK
+201.65%
Shattuck Labs Inc operates through a platform-based business model, focusing on the development of biotechnology products and solutions. By utilizing its proprietary technology and expertise, the company aims to create innovative therapies targeting various diseases and disorders, ultimately improving patient outcomes. Shattuck Labs Inc collaborates with strategic partners and stakeholders to advance its pipeline, aiming to commercialize its novel treatments and drive growth in the biotech industry.
|
ELVA
+209.80%
|
|
|
Electrovaya Inc
Industrial Machinery and Components Industry
ELVA
+209.80%
Electrovaya Inc is a company that operates on a business model centered around the manufacturing and distribution of advanced lithium-ion batteries for energy storage applications, providing efficient and reliable energy solutions to various industries such as automotive, renewable energy, and grid storage.
|
USAU
+214.59%
|
|
|
U s Gold Corp
Metal Mining Industry
USAU
+214.59%
U.S. Gold Corp operates as a gold exploration and development company. The company seeks to discover, acquire, and develop gold projects with the goal of advancing them into profitable mining operations.
|
TGEN
+218.71%
|
|
|
Tecogen Inc
Industrial Machinery and Components Industry
TGEN
+218.71%
Tecogen Inc*s business model revolves around providing energy-efficient and clean technology solutions for heating, cooling, and power generation.
|
MFI
+219.02%
|
|
|
Mf International Limited
Cloud Computing & Data Analytics Industry
MFI
+219.02%
A holding company with operating subsidiaries located in Hong Kong and the British Virgin Islands.
|
IMDX
+221.89%
|
|
|
Insight Molecular Diagnostics Inc
In Vitro & In Vivo Diagnostic Substances Industry
IMDX
+221.89%
The company develops molecular diagnostic test kits for detecting transplanted organ rejection.
|
ARMP
+222.05%
|
|
|
Armata Pharmaceuticals Inc
Biotechnology & Pharmaceuticals Industry
ARMP
+222.05%
Armata Pharmaceuticals Inc operates on a research and development business model focused on discovering and developing bacteriophage-based therapies to combat antibiotic-resistant infections. They utilize their proprietary phage technology platform to create novel pharmaceutical products targeting various bacterial diseases.
|
NEPH
+234.25%
|
|
|
Nephros Inc
Medical Equipment & Supplies Industry
NEPH
+234.25%
Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.
|
DRD
+243.79%
|
|
|
Drdgold Limited
Metal Mining Industry
DRD
+243.79%
Drdgold Limited*s business model revolves around the extraction and processing of gold from mining waste materials, known as tailings. The company focuses on reclaiming gold from mine dumps and reprocessing it to create value and generate profits.
|
CRVO
+254.26%
|
|
|
Cervomed Inc
Major Pharmaceutical Preparations Industry
CRVO
+254.26%
Cervomed Inc*s business model focuses on developing and commercializing medical devices to address neurological disorders. They aim to provide innovative solutions to improve the quality of life for patients suffering from conditions like chronic pain and epilepsy. Through their research and development efforts, Cervomed Inc aims to bring technologically advanced products to market, catering to the needs of healthcare professionals and patients worldwide.
|
GALT
+255.56%
|
|
|
Galectin Therapeutics Inc
Major Pharmaceutical Preparations Industry
GALT
+255.56%
Galectin Therapeutics Inc is a biotechnology company that focuses on developing therapies for fibrotic diseases and cancer by targeting galectin proteins. Their business model involves conducting research and development to create novel galectin-targeting drugs, partnering with pharmaceutical companies for joint development and commercialization, and potentially seeking regulatory approval for their products to enter the market. They generate revenue through licensing agreements, collaborations, and potential sales of their developed therapies.
|
OWLT
+267.95%
|
|
|
Owlet Inc
Scientific & Technical Instruments Industry
OWLT
+267.95%
Owlet Inc is a technology company that specializes in creating and selling smart baby monitors. Their business model revolves around developing innovative and reliable products that use advanced technology to monitor infants* health and provide peace of mind to parents.
|
WSTL
+311.81%
|
|
|
Westell Technologies Inc
Consumer Electronics Industry
WSTL
+311.81%
Westell Technologies Inc operates in the telecommunications industry, providing innovative and reliable solutions for wireless communication and networking.
|
SLGL
+315.17%
|
|
|
Sol gel Technologies Ltd
Major Pharmaceutical Preparations Industry
SLGL
+315.17%
Sol Gel Technologies Ltd is a specialty pharmaceutical company that focuses on the development and manufacturing of dermatological drugs. Their business model revolves around utilizing their proprietary sol gel technology to develop innovative pharmaceutical products with enhanced drug delivery and therapeutic benefits. They primarily generate revenue by licensing or partnering with pharmaceutical companies for the commercialization of their drug products.
|
PTHS
+328.77%
|
|
|
Pelthos Therapeutics Inc
Biotechnology & Pharmaceuticals Industry
PTHS
+328.77%
Pelthos Therapeutics Inc. commercializes therapeutic pharmaceutical products approved by the U.S. Food and Drug Administration (FDA).
|
|
PREV.